Kimia Biosciences share news, announcements and annual reports
BSE: 530313Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹30.45.
30 Oct: open ₹31.49, high ₹31.49, low ₹29.01
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹138 Cr2,580th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 19.20
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 7.79
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 51.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 19.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 1.95
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 237
Kimia Biosciences share news and announcements
546 announcements, routine notices left out, newest first. Page 2 of 11.
Sep 2025
Aug 2025
26 Aug · Board meeting
Meeting on 29 Aug 2025: annual general meeting14 Aug · Management
14 Aug · Results
8 Aug · Board meeting
Meeting on 14 Aug 2025: quarterly results4 Aug · Disclosure under Regulation 30A of LODR
Jul 2025
31 Jul · Disclosure under Regulation 30A of LODR
2 Jul · Legal
Exchange has sought clarification from Kimia Biosciences Ltd on July 2, 2025, with reference to Movement in Price. The reply is awaited.
Jun 2025
25 Jun · Board meeting
Meeting on 25 Jun 202525 Jun · Management
25 Jun · Disclosure under Regulation 30A of LODR
25 Jun · Disclosure under Regulation 30A of LODR
25 Jun · Disclosure under Regulation 30A of LODR
25 Jun · Disclosure under Regulation 30A of LODR
25 Jun · Board meeting
20 Jun · Board meeting
May 2025
29 May · Non-Applicability Of Regulation 24A Of SEBI(Listing Obligation And Disclosure ),Regulations,2015
28 May · Results
26 May · Board meeting
21 May · Board meeting
Meeting on 26 May 2025: audited results5 May · Board meeting
2 May · Board meeting
Meeting on 5 May 2025
Apr 2025
23 Apr · Management
23 Apr · Management
21 Apr · Board meeting
Meeting on 23 Apr 202519 Apr · Statement Of Investor Complaint, Regulation 13(3) Of SEBI LODR,2015
16 Apr · Non-Applicability Of Corporate Governance Report.